WASHINGTON, April 2 (UPI) -- The U.S. Food and Drug Administration has approved the first generic versions of Topamax tablets (topiramate) to prevent seizures.
FALLS CHURCH, Va., Feb. 17 (UPI) -- The U.S. Army has selected Vertex Solutions to participate in a contract vehicle to support Defense Department training and simulation requirements.
NEW YORK, Oct. 27 (UPI) -- The U.S. Navy has contracted an L-3 Communications subsidiary to provide logistics support for the Navy's trainer aircraft.
WASHINGTON, July 2 (UPI) -- The U.S. Food and Drug Administration has approved the first generic versions of Lamisil (terbinafine hydrochloride) tablets to treat nail fungus infection.
WASHINGTON, April 24 (UPI) -- The U.S. Food and Drug Administration has approved the first generic versions of Ambien (zolpidem tartrate) for the treatment of insomnia.
NEW BRUNSWICK, N.J., June 30 (UPI) -- Janssen and Vertex said Friday they entered into an agreement to develop and commercialize Vertex's VX-950 to treat hepatitis C.
WASHINGTON, Dec. 8 (UPI) -- The Food and Drug Administration has fast tracked Vertex Pharmaceuticals' oral hepatitis C (HVC) drug.
REYKJAVIK, Iceland, Oct. 18 (UPI) -- Iceland's Actavis Group will pay $810 million to buy Alpharma Inc.'s generic drug business.
WHITEHOUSE STATION, N.J., June 22 (UPI) -- Merck & Co. of Whitehouse Station, N.J., said Tuesday it entered into a global collaboration with Vertex Pharmaceuticals of Cambridge, Mass.
BOMBAY, March 29 (UPI) -- Lupin Pharmaceuticals Inc. of India has made a deal with Allergan Inc. of California to market a pediatric eye solution to treat bacterial conjunctivitis.
